Fan, Zibo
Liu, Yue
Xie, Hao
Yang, Qinfeng
Zhang, Guangqing
Zhang, Ping
Ding, Hong
Funding for this research was provided by:
National Key Research and Development Program of China Stem Cell and Translational Research (2021YFA1100601)
National Natural Science Foundation of China (32170799)
Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University (ZSQYRSSFAR0003)
Shenzhen Science and Technology Program (JCYJ20210324120804013)
Article History
Received: 29 February 2024
Accepted: 25 January 2025
First Online: 26 February 2025
Declarations
:
: This study utilized the NIS database, which provides anonymous and retrospective information from 2017 to 2019. It was considered exempt from ethics review by the Ethics Committee of Nanfang Hospital, Southern Medical University, under ethical approval number NFEC-2024–149. The research was conducted in accordance with local legislation and institutional requirements, and the Ethics Committee waived the need for written informed consent from participants or their legal guardians, as all data were anonymized and did not involve patient privacy. Furthermore, this study adheres to the standards set forth by the Helsinki Declaration.
: All data used in this study were anonymized, and the patients were informed and gave consent for the study to be published.
: The authors declare no competing interests.